Scott Platshon
CIK: 0001816539
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ZYME
Zymeworks Inc.
Officer
Discretionary Trading P&L
Holdings
About Platshon Scott
Platshon Scott (SEC CIK 0001816539) files insider reports with the SEC as EVP, Chief Business Officer of Zymeworks Inc. (ZYME).
Signal8 holds 2 ownership filings by Platshon Scott (1 Form 3, 1 Form 4), filed on Apr 10, 2026. Those filings report 3 transactions, the latest on Apr 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Platshon Scott's filings is in MIDDLETOWN, DE.
Recent filings by Platshon Scott
- Apr 9, 2026: Grants or awards of ZYME derivative securities (3 lines, Form 4, code A).
Other insiders filing for Zymeworks Inc. (ZYME)
- Schayowitz Adam, EVP, Head of R&D
- Hollywood Mark, EVP & Chief Operating Officer
- Schneider Paul R, EVP, General Counsel
- Stafford Kristin, EVP, Chief Financial Officer
- Mekan Sabeen, SVP & Chief Medical Officer
- Cherry Brian N, Director